塩野義製薬の株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2021/06/17 | 5,807 | 5,829 | 5,694 | 5,697 | -77 | -1.3% | 995,100 |
| 2021/06/16 | 5,799 | 5,874 | 5,762 | 5,774 | -63 | -1.1% | 1,299,700 |
| 2021/06/15 | 5,793 | 5,854 | 5,788 | 5,837 | +93 | +1.6% | 1,167,600 |
| 2021/06/14 | 5,769 | 5,800 | 5,721 | 5,744 | -47 | -0.8% | 1,085,800 |
| 2021/06/11 | 5,791 | 5,846 | 5,681 | 5,791 | -48 | -0.8% | 2,170,400 |
| 2021/06/10 | 5,764 | 6,086 | 5,759 | 5,839 | +192 | +3.4% | 4,134,700 |
| 2021/06/09 | 5,599 | 5,655 | 5,586 | 5,647 | +52 | +0.9% | 790,800 |
| 2021/06/08 | 5,625 | 5,657 | 5,587 | 5,595 | -2 | ±0% | 1,021,400 |
| 2021/06/07 | 5,650 | 5,659 | 5,571 | 5,597 | -30 | -0.5% | 570,500 |
| 2021/06/04 | 5,603 | 5,634 | 5,576 | 5,627 | +31 | +0.6% | 769,400 |
| 2021/06/03 | 5,511 | 5,606 | 5,495 | 5,596 | +86 | +1.6% | 883,000 |
| 2021/06/02 | 5,475 | 5,558 | 5,438 | 5,510 | +17 | +0.3% | 1,365,600 |
| 2021/06/01 | 5,585 | 5,591 | 5,471 | 5,493 | -64 | -1.2% | 1,056,300 |
| 2021/05/31 | 5,581 | 5,655 | 5,557 | 5,557 | -64 | -1.1% | 1,115,600 |
| 2021/05/28 | 5,648 | 5,693 | 5,615 | 5,621 | -3 | -0.1% | 1,206,000 |
| 2021/05/27 | 5,600 | 5,657 | 5,595 | 5,624 | +26 | +0.5% | 1,881,000 |
| 2021/05/26 | 5,671 | 5,679 | 5,598 | 5,598 | -63 | -1.1% | 1,334,900 |
| 2021/05/25 | 5,730 | 5,740 | 5,651 | 5,661 | -94 | -1.6% | 941,700 |
| 2021/05/24 | 5,798 | 5,835 | 5,754 | 5,755 | -54 | -0.9% | 720,200 |
| 2021/05/21 | 5,810 | 5,825 | 5,773 | 5,809 | +6 | +0.1% | 703,400 |
| 2021/05/20 | 5,773 | 5,830 | 5,742 | 5,803 | -7 | -0.1% | 743,700 |
| 2021/05/19 | 5,715 | 5,820 | 5,657 | 5,810 | +52 | +0.9% | 1,390,000 |
| 2021/05/18 | 5,740 | 5,811 | 5,711 | 5,758 | -13 | -0.2% | 1,522,400 |
| 2021/05/17 | 5,777 | 5,819 | 5,741 | 5,771 | +46 | +0.8% | 990,800 |
| 2021/05/14 | 5,699 | 5,770 | 5,691 | 5,725 | +38 | +0.7% | 1,726,800 |
| 2021/05/13 | 5,765 | 5,819 | 5,673 | 5,687 | -156 | -2.7% | 1,570,300 |
| 2021/05/12 | 5,870 | 6,058 | 5,804 | 5,843 | -23 | -0.4% | 2,161,100 |
| 2021/05/11 | 6,012 | 6,014 | 5,733 | 5,866 | +69 | +1.2% | 3,488,500 |
| 2021/05/10 | 5,666 | 5,807 | 5,651 | 5,797 | +134 | +2.4% | 1,063,500 |
| 2021/05/07 | 5,696 | 5,736 | 5,650 | 5,663 | -72 | -1.3% | 1,017,900 |
| 2021/05/06 | 5,601 | 5,767 | 5,601 | 5,735 | -12 | -0.2% | 1,191,600 |
| 2021/04/30 | 5,780 | 5,794 | 5,710 | 5,747 | -7 | -0.1% | 892,400 |
| 2021/04/28 | 5,677 | 5,760 | 5,668 | 5,754 | +71 | +1.2% | 759,300 |
| 2021/04/27 | 5,730 | 5,749 | 5,671 | 5,683 | -31 | -0.5% | 616,500 |
| 2021/04/26 | 5,687 | 5,736 | 5,629 | 5,714 | -13 | -0.2% | 687,800 |
| 2021/04/23 | 5,664 | 5,729 | 5,634 | 5,727 | +51 | +0.9% | 548,900 |
| 2021/04/22 | 5,604 | 5,683 | 5,591 | 5,676 | +131 | +2.4% | 747,000 |
| 2021/04/21 | 5,557 | 5,597 | 5,530 | 5,545 | -101 | -1.8% | 970,400 |
| 2021/04/20 | 5,657 | 5,692 | 5,601 | 5,646 | -24 | -0.4% | 920,600 |
| 2021/04/19 | 5,612 | 5,740 | 5,547 | 5,670 | -58 | -1% | 1,292,600 |
| 2021/04/16 | 5,819 | 5,819 | 5,727 | 5,728 | -98 | -1.7% | 767,800 |
| 2021/04/15 | 5,850 | 5,902 | 5,812 | 5,826 | +64 | +1.1% | 472,000 |
| 2021/04/14 | 5,757 | 5,804 | 5,717 | 5,762 | -4 | -0.1% | 796,500 |
| 2021/04/13 | 5,787 | 5,790 | 5,735 | 5,766 | +11 | +0.2% | 695,400 |
| 2021/04/12 | 5,844 | 5,844 | 5,753 | 5,755 | -95 | -1.6% | 554,700 |
| 2021/04/09 | 5,820 | 5,898 | 5,787 | 5,850 | +110 | +1.9% | 1,025,300 |
| 2021/04/08 | 5,793 | 5,796 | 5,709 | 5,740 | -42 | -0.7% | 641,800 |
| 2021/04/07 | 5,810 | 5,843 | 5,771 | 5,782 | -86 | -1.5% | 944,900 |
| 2021/04/06 | 5,948 | 5,989 | 5,864 | 5,868 | -93 | -1.6% | 696,400 |
| 2021/04/05 | 5,958 | 5,997 | 5,953 | 5,961 | +61 | +1% | 474,700 |
951～
1000
件表示中 / 3694件
類似銘柄と比較する
現在ご覧いただいている「塩野義」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| 塩野義 | 236,600円 | +5.7% | +3.9% | 2.59% | 11.77倍 | 1.56倍 |
|
抗ＨＩＶ薬が大型製品に。感染症、疼痛・中枢神経領域に強み。米国に積極展開。欧州、アジア開拓 |
| 大塚ＨＤ | 723,600円 | +2.2% | +10.2% | 1.66% | 13.90倍 | 1.40倍 |
|
国内製薬大手で抗精神病薬が主力。ポカリスエットなど機能性食品も拡大。世界９０カ所に工場 |
| アステラス薬 | 140,800円 | +0.9% | +380.2% | 5.54% | 19.39倍 | 1.67倍 |
|
医薬品国内２位。開発技術起点の研究開発体制。前立腺がん薬が柱。遺伝子・細胞治療技術育成 |
| エーザイ | 401,800円 | +1.7% | -2.9% | 3.98% | 26.36倍 | 1.38倍 |
|
神経系、がん領域に強み。認知症薬は米バイオジェンと、抗がん薬では米メルクと国際協業推進 |
| 協和キリン | 218,900円 | -3.5% | -11.3% | 2.74% | 20.11倍 | 1.35倍 |
|
キリン傘下。医薬品、バイオが主力。独自の抗体高活性化技術に強み。富士フイルムと提携 |
市場注目の銘柄
チャート関連のコラム
